Read this article in Pharmaceutical Technology’s September 2021 Regulatory Sourcebook eBook.. Article Details. Pharmaceutical Technology eBook: Regulatory Sourcebook September 2021 Pages: 4–7.

FDA published guidance on Dec. 3, 2020 on how sponsors of combination products can obtain feedback from the agency regarding scientific and regulatory questions. The guidance also offers best ...

A new combination product comprising the triptan rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam has shown promising results in the treatment of migraine. In the phase 3 ...

“The combination of Kindeva and Meridian creates a clear market leader in the drug-device CDMO sector. Customers will benefit from our enhanced scale and broader array of drug delivery solutions ...

CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the 'Company') announced that the Company received marketing authorization in China from National ...

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway – ALTO-207 ...

MOUNTAIN VIEW, Calif., June 03, 2025--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

AgBiome, which develops biological products for agricultural applications, aims to bring another piece to the farmer’s pest management tool kit with a combination product intended to address ...